Company intelligence / Profile preview

Clearsynth

Mumbai, Maharashtra, Indiapubchem.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Clearsynth does not conduct clinical trials or report clinical results. It specializes in the synthesis of deuterium-labelled compounds, stable isotopes, metabolites, impurities, chiral compounds, conjugate impurities, and complex molecules for use in pharmaceutical R&D and quality control. It also acts as a CDMO for building blocks and bulk deuterium compounds.

Modalities: Small moleculeBiologicStable isotope labelled compoundDeuterium labelled compoundMetabolite (as research tool)Chiral compound (as research tool)
Industry: Contract Manufacturing Organization

Partnerships

No major disclosed partnerships with pharmaceutical or biotech companies; distributes via partners such as Copenhagen Biotech Supply in Denmark.

Beyond the preview

Go deeper on Clearsynth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clearsynth.

Explore the full profile